fluorodeoxyglucose f18 has been researched along with Cancer of Gastrointestinal Tract in 122 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (3.28) | 18.2507 |
| 2000's | 46 (37.70) | 29.6817 |
| 2010's | 58 (47.54) | 24.3611 |
| 2020's | 14 (11.48) | 2.80 |
| Authors | Studies |
|---|---|
| Gai, Y; Lan, X; Liu, F; Liu, H; Liu, Q; Qin, C; Ruan, W; Song, Y; Tao, K; Zhang, P; Zhang, T; Zheng, D | 1 |
| Mandelkern, M; Menon, N | 1 |
| Harada, M; Otomi, Y; Otsuka, H; Shinya, T; Shono, N | 1 |
| Barrs, C; Bhosale, P; Francis, IR; Iravani, A; Itani, M; Mhlanga, J; Morani, A; Yano, M; Zulfiqar, M | 1 |
| Buck, AK; Hartrampf, PE; Higuchi, T; Kosmala, A; Lindner, T; Michalski, K; Schirbel, A; Schlötelburg, W; Serfling, SE; Weich, A; Werner, RA | 1 |
| Bailey, DL; Bernard, E; Caplin, ME; Chan, DL; Conner, A; Flamen, P; Furtado O'Mahony, L; Gnanasegaran, G; Hayes, AR; Karfis, I; Marin, C; Marin, G; Mileva, M; Navalkissoor, S; Pavlakis, N; Roach, P; Schembri, G; Toumpanakis, C; Vanderlinden, B | 1 |
| Du, C; Shao, G; Tian, R; Wang, F; Xie, Q; Yang, Z; Yao, X; Yu, F; Yu, J; Zang, S; Zhang, C; Zhang, P | 1 |
| Calapaquí Terán, AK; Delgado Bolton, RC; Fanti, S; Giammarile, F; Herrmann, K | 1 |
| Halanaik, D; Meenakshi, LA; Pottakkat, B; Rajaraman, V; Selvaraj, AJ | 1 |
| Abe, O; Akamatsu, N; Hasegawa, K; Hinata, M; Kanemaru, N; Nakai, Y; Nakao, T; Nakazawa, A; Ushiku, T; Watadani, T | 1 |
| Arçay Öztürk, A; Flamen, P | 1 |
| Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J | 1 |
| Jayaprakasam, VS; Paroder, V; Schöder, H | 1 |
| Howard, BA; Wong, TZ | 1 |
| Farahani, ZA; Hess, S; Tind, S; Vestergaard, S | 1 |
| Boonstra, PA; Desar, I; Farag, S; Gelderblom, H; Geus-Oei, LF; Grunhagen, D; Reyners, AKL; Steeghs, N; van Coevorden, F; van der Graaf, WT | 1 |
| Kim, SJ; Lee, SW | 1 |
| Ayubi, E; Safiri, S | 1 |
| Doi, H; Hirata, K; Kaida, H; Kitajima, K; Minamimoto, R; Nakajo, M; Sofue, K; Tamaki, Y; Tsurusaki, M; Ueno, Y; Yamakado, K | 1 |
| Cao, N; Ge, L; Lu, C; Pan, B; Wei, K; Yang, H | 1 |
| Fowler, KJ; Fraum, TJ; Hope, TA; Ludwig, DR | 1 |
| Albano, D; Alongi, P; Ganduscio, G; Gentile, R; Grassedonio, E; Laudicella, R; Midiri, M; Pompei, G; Raimondo, D; Rossi, F; Russo, G; Scalisi, S; Sinagra, E; Stefano, A | 1 |
| Alafate, A; Fujiwara, T; Gobara, H; Hiraki, T; Ishii, H; Kaji, M; Kanazawa, S; Kato, K; Miyoshi, S; Okumura, Y; Sato, S; Shinya, T | 1 |
| Dunet, V; Koehli, M; Meuli, R; Montemurro, M; Prior, JO; Schmidt, S | 1 |
| Cho, SH; Kim, JY; Kim, MJ; Kim, SH; Kim, YH; Lee, HJ; Won, KS | 1 |
| Banks, KP; Song, WS | 1 |
| Bendell, JC; Burris, HA; Hoh, CK; Infante, JR; Kim, S; Reid, TR; Rosbrook, B; Tarazi, J | 1 |
| Fujikuni, N; Misumi, T; Ohdan, H; Suzuki, T; Tanabe, K; Tokumoto, N | 1 |
| Irie, T; Izumiyama, K; Miyashita, K; Miyazaki, M; Mori, A; Morioka, M; Saito, M; Tanaka, M; Tanaka, S; Tanino, M; Tsukamoto, E | 1 |
| Dimitrakopoulou-Strauss, A; Hohenberger, P; Niedermoser, S; Ronellenfitsch, U; Wängler, B | 1 |
| Basu, S; Shrikhande, SV; Sirohi, B | 1 |
| Boellaard, R; Frings, V; Hayes, W; Hoekstra, OS; van de Ven, PM; van Velden, FH; Velasquez, LM | 1 |
| Adler, L; Biersack, HJ; Ezziddin, S; Fischer, HP; Grabellus, F; Höller, T; Nagarajah, J; Pöppel, TD; Sabet, A; Simon, B; Yüce, A | 1 |
| Hawkins, M; Partridge, M; Wilson, JM | 1 |
| Dai, T; Popa, E; Shah, MA | 1 |
| Decker, J; Dunzinger, A; Kieberger, A; Pichler, R; Weis, S | 1 |
| Akhurst, T; Eu, P; Hicks, RJ; Hofman, MS; Kashyap, R; Kong, G; Michael, M; Zannino, D | 1 |
| Fingerle, AA; Holzapfel, K; Maegerlein, C; Rummeny, EJ; Souvatzoglou, M | 1 |
| Herrmann, KA; Kohan, AA; Paspulati, RM; Rong, R; Teixera, SR | 1 |
| Chacón, M; Eleta, M; Espindola, AR; Méndez, G; Pupareli, C; Roca, E; Rojo, S | 1 |
| Donswijk, ML; Hess, S; Lam, MG; Mulders, T | 1 |
| Kumar, A; Kumar, R; Shamim, SA | 1 |
| Baba, A; Fugo, K; Fukamizu, Y; Hasegawa, R; Ishige, N; Kagayama, S; Kishimoto, T; Koike, N; Motoyoshi, Y; Oshima, Y; Ozaki, A; Shinozaki, F; Shirai, Y; Sugiyama, E; Sugiyama, T; Sunaoshi, T; Tomizawa, M; Toshimitsu, Y; Uchida, Y; Uchiyama, K; Yamamoto, S | 1 |
| Liu, Y; Xu, B | 1 |
| Cho, A; Cho, MH; Kim, H; Kim, WK; Park, CK; Park, M | 1 |
| Asady, H; Fard-Esfahani, A; Hassanzadeh-Rad, A; Hosseini, M; Katal, S; Moghadas Jafari, A; Yousefifard, M | 1 |
| Higashi, T; Mikami, Y; Minami, S; Miyake, KK; Nakamoto, Y; Saga, T; Tadamura, E; Tanaka, S; Togashi, K | 1 |
| Amantea, MA; Friberg, LE; Karlsson, MO; Schindler, E | 1 |
| Nguyen, BD; Sugrue, G | 1 |
| Basuroy, R; Ramage, JK; Srirajaskanthan, R | 1 |
| Higashi, T; Nakamoto, Y; Saga, T; Yoshikawa, K | 1 |
| Csiki, Z; Garai, I; Sóvágó, J; Szabados, L; Tóth, C; Tóth, L | 1 |
| Aschoff, P; Beckert, S; Brücher, BL; Glatzle, J; Hartmann, JT; Königsrainer, A; Königsrainer, I; Miller, S; Pfannenberg, C; Schroeder, TH; Zieker, D | 1 |
| Bergman, J; Kauhanen, S; Korsoff, P; Minn, H; Nuutila, P; Ovaska, J; Salmela, P; Saltevo, J; Sane, T; Seppänen, M; Välimäki, M | 1 |
| Bouchard, P; Duron, F; Grangé, JD; Houry, S; Huchet, V; Kerrou, K; Lotz, JP; Montravers, F; Nataf, V; Rougier, P; Ruszniewski, P; Talbot, JN | 1 |
| Antoch, G; Baumeister, R; Bockisch, A; Forsting, M; Hahn, S; Hamami, ME; Heusner, TA; Kim, UH; Stahl, A | 1 |
| Hany, TF; Husmann, L; Schaefer, NG; Soyka, JD; Strobel, K; Treyer, V; Tschopp, A; Veit-Haibach, P | 1 |
| Boellaard, R; Galbraith, SM; Hayes, W; Hoekstra, OS; Kollia, G; Lammertsma, AA; Velasquez, LM | 1 |
| Hata, Y; Homma, S; Isobe, K; Sakaguchi, S; Shibuya, K; Takagi, K; Takai, Y | 1 |
| Lin, Q; Luo, ZM; Sun, L; Sun, YH; Wan, Y; Wu, H; Zhao, L | 1 |
| Haustermans, K; Lambrecht, M | 1 |
| Antoch, G; Bauer, S; Bockisch, A; Ebeling, P; Forsting, M; Hahn, S; Hamami, ME; Heusner, TA; Stahl, A | 1 |
| Ding, HJ; Hsieh, TC; Kao, CH; Sun, SS; Wang, CH; Wu, YC; Yeh, JJ; Yen, KY | 1 |
| Anthony, MP; Chan, Q; Chu, KM; Chu, YC; Gong, N; Khong, PL; Lee, HF; Wong, CS | 1 |
| Hu, SL; Shi, W; Xu, JY; Yang, ZY; Zhang, YJ; Zhu, BL | 1 |
| Choi, H | 1 |
| Cui, L; Gao, J; Guan, Z; Shen, Z; Tian, J; Wang, H; Xu, B; Yao, S | 1 |
| Balasubramanian Harisankar, CN; Bhattacharya, A; Kashyap, R; Malhotra, P; Manohar, K; Rai Mittal, B; Singh, B; Varma, S | 1 |
| Hatazawa, J; Isohashi, K; Kato, H; Shimosegawa, E; Tatsumi, M; Watabe, H; Watabe, T; Yanagawa, M | 1 |
| Banerjee, P; Kung, AL; Tseng, JC; Wang, Y | 1 |
| Aflalo-Hazan, V; Aparicio, T; Barrau, V; Benamouzig, R; Des Guetz, G; Douard, R; Eder, V; Mehanna, Z; Pop, G; Rust, E; Soussan, M; Wind, P | 1 |
| Blevins, M; de Vries, DJ; Eisenberg, B; Gatsonis, C; Godwin, AK; Huang, M; Melenevsky, Y; Rink, L; Sicks, J; Siegel, BA; Szot-Barnes, A; Van den Abbeele, AD; Yap, JT | 1 |
| Dimitrakopoulou-Strauss, A; Hohenberger, P; Koczan, D; Pan, L; Strauss, LG | 1 |
| Carrió-Gasset, I; Fuertes-Cabero, S; García-Garzón, JR; Lomeña-Caballero, F; Moragas-Solanes, M; Ponce-López, A; Riera-Gil, E; Soler-Peter, M; Valls-Ferrusola, E | 1 |
| Cheng, J; Dai, D; Ma, WC; Song, XY; Xu, WG; Xu, XX; Zhu, L; Zhu, X | 1 |
| Cook, GJ | 1 |
| Iwata, T; Kashihara, H; Kurita, N; Matsumoto, N; Miyatani, T; Morimoto, S; Sato, H; Shimada, M; Takasu, C; Yoshikawa, K | 1 |
| Araki, M; Fujiki, S; Imagawa, A; Inaba, T; Iwamuro, M; Kawahara, Y; Kawai, Y; Mizuno, M; Morito, T; Nishimura, M; Okada, H; Shinagawa, K; Shiode, J; Suzuki, S; Takaki, A; Takata, K; Yamamoto, K; Yoshino, T | 1 |
| Hornick, JL; Jagannathan, JP; Koch, MR; Krajewski, KM; Ramaiya, NH; Raut, CP; Shinagare, AB | 1 |
| Colombet-Lamau, C; De Beco, V; Grahek, D; Kerrou, K; Mabille, L; Montravers, F; Petegnief, Y; Talbot, JN; Younsi, N; Zerbib, E | 1 |
| Badawi, RD; Van den Abbeele, AD | 1 |
| Chander, S; Lay Ergun, E; Shields, AF | 1 |
| Lilien, DL; Reddy, MP; Reddy, P | 1 |
| Buchmann, I; Gfrörer, W; Glatting, G; Kotzerke, J; Leithäuser, F; Möller, P; Reske, SN; Schulte, M; Schultheiss, S; Vogg, AT | 1 |
| Cole, P; Dimitrijevic, S; Dumez, H; Dupont, P; Goeminne, J; Martens, M; Mortelmans, L; Nuyts, J; Sciot, R; Seegers, M; Silberman, S; Stroobants, S; van den Borne, B; van Oosterom, A | 1 |
| Fulham, MJ; Wilkinson, MD | 1 |
| Annovazzi, A; Dierckx, R; Maenhout, A; Peeters, M; Signore, A; Van De Wiele, C | 1 |
| Berthelsen, AK; Eigtved, AI; Kinnander, C; Krarup-Hansen, A | 1 |
| Gayed, I; Iyer, R; Johnson, M; Macapinlac, H; Podoloff, D; Swanston, N; Vu, T | 1 |
| Larson, SM; Schöder, H; Yeung, HW | 1 |
| Donckier, V; Feron, P; Gelin, M; Goldman, S; Ickx, B; Van Gansbeke, D; Van Laethem, JL; Wikler, D | 1 |
| Coit, DG; Wong, SL | 1 |
| Gietema, JA; Jager, PL; van der Graaf, WT | 1 |
| Berner, U; Döbert, N; Grünwald, F; Menzel, Ch; Wördehoff, N | 1 |
| Ichiya, T; Ishibashi, Y; Ito, T; Miyazaki, H; Nishimura, M; Okushiba, S; Tsukidate, N | 1 |
| Hustinx, R | 1 |
| Alavi, A; Dadparvar, S; Dhurairaj, T; Kumar, R; Mavi, A; Potenta, S; Xiu, Y; Yu, JQ; Zhuang, H | 1 |
| Fried, M; Kamel, EM; Padberg, B; Schiesser, M; Schneiter, D; Stoeckli, SJ; Stumpe, KD; Thumshirn, M; Truninger, K; von Schulthess, GK | 1 |
| Bouhnik, JP; Even-Sapir, E; Lerman, H; Levin, C; Lievshitz, G; Miller, E; Yuzefovich, B; Zak, O | 1 |
| Kato, H; Kuwano, H; Sohda, M | 1 |
| Barghouth, G; Dizendorf, E; Goerres, GW; Hany, TF; Leyvraz, S; Luthi, F; Pestalozzi, B; Schnyder, P; Stupp, R; von Schulthess, GK | 1 |
| Drenth, JP; Jansen, JB; Nagengast, FM; Oyen, WJ; van Kouwen, MC | 1 |
| Eriksson, B; Oberg, K | 1 |
| Bar-Shalom, R; Fischer, D; Frenkel, A; Israel, O; Kagana, O; Keidar, Z; Yefremov, N | 1 |
| Siewert, JR; Stein, HJ; von Rahden, BH | 1 |
| Fischman, AJ; Hahn, PF; Kalva, SP; Mueller, P; Ryan, D; Sahani, DV; Saini, S | 1 |
| Faria, SC; Kazama, T; Macapinlac, HA; Mar, MV; Phongkitkarun, S; Podoloff, DA; Varavithya, V | 1 |
| Chang, PP; Chin, BB | 1 |
| Kim, BI; Yun, M | 1 |
| Ameshima, S; Demura, Y; Ishizaki, T; Kadowaki, M; Miyamori, I; Mizuno, S; Morikawa, M; Nakanishi, M; Sasaki, M; Uesaka, D; Umeda, Y | 1 |
| Bourguet, P; Metges, JP; Mitry, E; Monteil, J; Planchamp, F; Tubiana-Mathieu, N | 1 |
| Hemandas, AK; Hickish, T; Robson, NK; Talbot, RW | 1 |
| Harada, A; Hayasaka, K; Ito, K; Katoh, T; Kawabata, Y; Matsuura, T; Nakashima, K; Nihashi, T; Sakata, K; Yagi, T | 1 |
| Buchmann, I; Ganten, TM; Haberkorn, U | 1 |
| Bradfield, H; Gupta, N | 1 |
| Bausart, R; Declerck, P; Delval, D; Jamar, F; Lonneux, M; Moens, R; Pauwels, S; Van Mael, P; Willockx, R; Zreik, H | 1 |
| Daenen, F; Detroz, B; Honoré, P; Hustinx, R; Jacquet, N; Paulus, P; Rigo, P | 1 |
| Aliberti, G; Bombardieri, E; Crippa, F; de Graaf, C; Pauwels, E | 1 |
| Altehoefer, C; Ghanem, N; Hoegerle, S; Koehler, G; Moser, E; Nitzsche, E; Scheruebl, H; Waller, CF | 1 |
| Dimitrijevic, S; Donato di Paola, E; Judson, I; Martens, M; Nielsen, OS; Sciot, R; Silberman, S; Stroobants, S; Van Glabbeke, M; van Oosterom, AT; Verweij, J; Webb, A | 1 |
| Ladabaum, U | 1 |
| Arimizu, N; Asano, T; Enomoto, K; Fukunaga, T; Imazeki, K; Isono, K; Itoh, Y; Kikuchi, T; Okazumi, S; Yamamoto, H | 1 |
40 review(s) available for fluorodeoxyglucose f18 and Cancer of Gastrointestinal Tract
| Article | Year |
|---|---|
Are We Approaching a Change in Paradigm in PET/CT Imaging of Solid Gastrointestinal (or Digestive) Tract Tumors With the Clinical Application of FAPI Imaging?
Topics: Fluorodeoxyglucose F18; Gallium Radioisotopes; Gastrointestinal Neoplasms; Humans; Positron Emission Tomography Computed Tomography | 2023 |
Multimodal imaging findings of intrahepatic cholangiocarcinoma arising from a biliary adenofibroma: a case report with radiological-pathological correlation.
Topics: Adenofibroma; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Middle Aged; Multimodal Imaging | 2023 |
FAP-targeted PET imaging in gastrointestinal malignancies: a comprehensive review.
Topics: Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Liver; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Tumor Microenvironment | 2023 |
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Variants and Pitfalls in PET/CT Imaging of Gastrointestinal Cancers.
Topics: Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Tissue Distribution; Tomography, X-Ray Computed | 2021 |
18F-FDG-PET/CT Imaging for Gastrointestinal Malignancies.
Topics: Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2021 |
Positron emission tomography/computer tomography in gastrointestinal malignancies: current potential and challenges.
Topics: Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Stomach Neoplasms | 2017 |
Performance of F-18 FDG PET/CT for predicting malignant potential of gastrointestinal stromal tumors: A systematic review and meta-analysis.
Topics: Databases, Bibliographic; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity | 2018 |
Present and future roles of FDG-PET/CT imaging in the management of gastrointestinal cancer: an update.
Topics: Animals; Colorectal Neoplasms; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Positron Emission Tomography Computed Tomography; Stomach Neoplasms; Tomography, X-Ray Computed | 2017 |
F-18 FDG PET, CT, and MRI for detecting the malignant potential in patients with gastrointestinal stromal tumors: A protocol for a network meta-analysis of diagnostic test accuracy.
Topics: Early Detection of Cancer; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Research Design; Tomography, X-Ray Computed | 2018 |
PET/MRI for Gastrointestinal Imaging: Current Clinical Status and Future Prospects.
Topics: Early Detection of Cancer; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Gastrointestinal Tract; Humans; Magnetic Resonance Imaging; Neoplasm Staging; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2018 |
Role of positron emission tomography-computed tomography in gastrointestinal malignancies.
Topics: Contrast Media; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Radionuclide Imaging; Radiopharmaceuticals | 2013 |
The application of functional imaging techniques to personalise chemoradiotherapy in upper gastrointestinal malignancies.
Topics: Chemoradiotherapy; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Positron-Emission Tomography; Precision Medicine; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
The role of ¹⁸F-FDG PET imaging in upper gastrointestinal malignancies.
Topics: Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Pancreatic Neoplasms; Positron-Emission Tomography; Upper Gastrointestinal Tract | 2014 |
Potential role of positron emission tomography/magnetic resonance imaging in gastrointestinal and abdominal malignancies: preliminary experience.
Topics: Abdominal Neoplasms; Digestive System; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Gastrointestinal Tract; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals | 2014 |
[18F]Fluorodeoxyglucose PET/Computed Tomography in Gastrointestinal Malignancies.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Liver Neoplasms; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms; Tomography, X-Ray Computed | 2014 |
PET/Computed Tomography in Neuroendocrine Tumor: Value to Patient Management and Survival Outcomes.
Topics: Adrenal Gland Neoplasms; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Gallium Radioisotopes; Gastrointestinal Neoplasms; Humans; Multimodal Imaging; Neuroendocrine Tumors; Pancreatic Neoplasms; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy; Thyroid Neoplasms; Tomography, X-Ray Computed | 2015 |
The value of (18) F-fluorodeoxyglucose positron emission tomography for prediction of treatment response in gastrointestinal stromal tumors: a systematic review and meta-analysis.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Male; Middle Aged; Odds Ratio; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Reproducibility of Results; Treatment Outcome; Young Adult | 2016 |
Neuroendocrine Tumors.
Topics: Antineoplastic Agents; Antineoplastic Agents, Hormonal; Chromogranin A; Digestive System Surgical Procedures; Embolization, Therapeutic; Fluorodeoxyglucose F18; Gallium Radioisotopes; Gastrointestinal Neoplasms; Hepatic Artery; Humans; Hydroxyindoleacetic Acid; Liver Neoplasms; Magnetic Resonance Imaging; Malignant Carcinoid Syndrome; Metastasectomy; Neoplasm Staging; Neuroendocrine Tumors; Octreotide; Organometallic Compounds; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Receptors, Somatostatin; Serotonin; Tomography, X-Ray Computed | 2016 |
Positron emission tomography for the diagnosis and management of patients with gastrointestinal malignancies.
Topics: Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, Emission-Computed | 2008 |
[Metabolic imaging--PET, PET/CT--in oncologic surgery].
Topics: Breast Neoplasms; Cost-Benefit Analysis; Endocrine Gland Neoplasms; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Head and Neck Neoplasms; Humans; Hungary; Lung Neoplasms; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Surgical Procedures, Operative; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2008 |
[Selection criteria for peritonectomy with hyperthermic intraoperative chemotherapy (HIPEC) in peritoneal carcinomatosis].
Topics: Antineoplastic Agents; Carcinoma; Chemotherapy, Cancer, Regional Perfusion; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Genital Neoplasms, Female; Humans; Hyperthermia, Induced; Laparoscopy; Patient Selection; Peritoneal Neoplasms; Peritoneum; Positron-Emission Tomography; Prognosis; Tomography, X-Ray Computed | 2008 |
Clinical evidence on PET-CT for radiation therapy planning in gastro-intestinal tumors.
Topics: Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Positron-Emission Tomography; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed | 2010 |
Imaging modalities of gastrointestinal stromal tumors.
Topics: Endosonography; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2011 |
Extranodal manifestations of lymphoma on [¹⁸F]FDG-PET/CT: a pictorial essay.
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphoma; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Skin Neoplasms; Tomography, X-Ray Computed | 2011 |
[Value of [18F]-fluorodeoxyglucose (FDG) positron emission tomography in digestive cancerology].
Topics: Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Neoplasm Recurrence, Local; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2002 |
Use of positron emission tomography in oncology and its potential role to assess response to imatinib mesylate therapy in gastrointestinal stromal tumors (GISTs).
Topics: Antineoplastic Agents; Benzamides; Drug Monitoring; Enzyme Inhibitors; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Imatinib Mesylate; Neoplasms, Connective Tissue; Piperazines; Pyrimidines; Radiopharmaceuticals; Stromal Cells; Tomography, Emission-Computed; Treatment Outcome | 2002 |
FDG PET imaging of metastatic gastrointestinal stromal tumor.
Topics: Abdominal Neoplasms; Aged; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Stromal Cells; Tomography, Emission-Computed | 2003 |
18-fluorodeoxyglucose positron emission tomography in nonendocrine neoplastic disorders of the gastrointestinal tract.
Topics: Biliary Tract Neoplasms; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Liver Neoplasms; Neoplasm Staging; Pancreatic Neoplasms; Tomography, Emission-Computed | 2003 |
PET/CT in oncology: integration into clinical management of lymphoma, melanoma, and gastrointestinal malignancies.
Topics: Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Lymphoma; Melanoma; Neoplasm Recurrence, Local; Neoplasm Staging; Patient Care Management; Radiopharmaceuticals; Subtraction Technique; Systems Integration; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2004 |
Role of surgery in patients with stage IV melanoma.
Topics: Brain Neoplasms; Decision Making; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Lung Neoplasms; Melanoma; Neoplasm Staging; Palliative Care; Radiography; Radiopharmaceuticals; Risk Factors; Tomography, Emission-Computed | 2004 |
PET imaging in assessing gastrointestinal tumors.
Topics: Carcinoma; Colorectal Neoplasms; Esophageal Neoplasms; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Neoplasm Staging; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals | 2004 |
[Diagnosis of gastrointestinal tract malignancies using positron emission tomography (PET) with 18F-fluorodeoxyglucose (FDG)].
Topics: Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Gastroscopy; Humans; Lymph Nodes; Lymphatic Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms; Tomography, X-Ray Computed | 2004 |
FDG-PET scanning in the diagnosis of gastrointestinal cancers.
Topics: Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2004 |
Nuclear medicine in the detection, staging and treatment of gastrointestinal carcinoid tumours.
Topics: 3-Iodobenzylguanidine; Carcinoid Tumor; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Neoplasm Staging; Nuclear Medicine; Positron-Emission Tomography; Radionuclide Imaging; Radiopharmaceuticals; Somatostatin | 2005 |
Gastrointestinal malignancies evaluated with (18)F-fluoro-2-deoxyglucose positron emission tomography.
Topics: Clinical Trials as Topic; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Positron-Emission Tomography; Radiopharmaceuticals | 2006 |
[Recommendations for clinical practice: use of TEP-FDG in cancer of the esophagus, stomach, colon and rectum, anal canal, large intestine, pancreas and bile ducts, liver and endocrine tumors (digestive system)].
Topics: Anus Neoplasms; Bile Duct Neoplasms; Colorectal Neoplasms; Digestive System Neoplasms; Endocrine Gland Neoplasms; Esophageal Neoplasms; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Intestine, Large; Liver Neoplasms; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms | 2007 |
[[18F]-FDG-PET in the diagnostics of gastrointestinal tumors].
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Cholangiocarcinoma; Colonic Neoplasms; Esophageal Neoplasms; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Liver Neoplasms; Meta-Analysis as Topic; Neoplasm Recurrence, Local; Neoplasm Staging; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
[Role of positron emission tomography is the evaluation of digestive tract tumors].
Topics: Colorectal Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Pancreatic Neoplasms; Pancreatitis; Tomography, Emission-Computed | 1999 |
Positron emission tomography (PET) and other nuclear medicine modalities in staging gastrointestinal cancer.
Topics: Antibodies, Monoclonal; Diagnosis, Differential; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Neoplasm Staging; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Somatostatin; Tomography, Emission-Computed | 2001 |
16 trial(s) available for fluorodeoxyglucose f18 and Cancer of Gastrointestinal Tract
| Article | Year |
|---|---|
Gallium-68-labeled fibroblast activation protein inhibitor PET in gastrointestinal cancer: insights into diagnosis and management.
Topics: Fibroblasts; Fluorodeoxyglucose F18; Gallium Radioisotopes; Gastrointestinal Neoplasms; Humans; Membrane Proteins; Positron Emission Tomography Computed Tomography; Quinolines | 2022 |
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Intermittent dosing of axitinib combined with chemotherapy is supported by (18)FLT-PET in gastrointestinal tumours.
Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Axitinib; Bevacizumab; Camptothecin; Female; Fluorodeoxyglucose F18; Fluorouracil; Gastrointestinal Neoplasms; Humans; Imidazoles; Indazoles; Leucovorin; Male; Maximum Tolerated Dose; Middle Aged; Organoplatinum Compounds; Positron-Emission Tomography; Protein Kinase Inhibitors; Radiopharmaceuticals; Withholding Treatment | 2014 |
Repeatability of metabolically active tumor volume measurements with FDG PET/CT in advanced gastrointestinal malignancies: a multicenter study.
Topics: Canada; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Tomography, X-Ray Computed; United States | 2014 |
Favourable outcomes of (177)Lu-octreotate peptide receptor chemoradionuclide therapy in patients with FDG-avid neuroendocrine tumours.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Male; Middle Aged; Neuroendocrine Tumors; Octreotide; Pancreatic Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Treatment Outcome | 2015 |
PK-PD modeling of individual lesion FDG-PET response to predict overall survival in patients with sunitinib-treated gastrointestinal stromal tumor.
Topics: Adult; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Indoles; Models, Biological; Models, Statistical; Nonlinear Dynamics; Positron-Emission Tomography; Pyrroles; Radiopharmaceuticals; Sunitinib; Survival Analysis; Survival Rate; Treatment Outcome; Tumor Burden | 2016 |
The clinical value of [18F]fluoro-dihydroxyphenylalanine positron emission tomography in primary diagnosis, staging, and restaging of neuroendocrine tumors.
Topics: Adrenal Gland Neoplasms; Adult; Carcinoma, Medullary; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Male; Middle Aged; Neoplasm Staging; Neuroendocrine Tumors; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Thyroid Neoplasms | 2009 |
Repeatability of 18F-FDG PET in a multicenter phase I study of patients with advanced gastrointestinal malignancies.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Male; Middle Aged; Positron-Emission Tomography; Quality Control; Reproducibility of Results; Research Design | 2009 |
ACRIN 6665/RTOG 0132 phase II trial of neoadjuvant imatinib mesylate for operable malignant gastrointestinal stromal tumor: monitoring with 18F-FDG PET and correlation with genotype and GLUT4 expression.
Topics: Adult; Aged; Aged, 80 and over; Benzamides; Biological Transport; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Gene Expression Regulation, Neoplastic; Genotype; Glucose Transporter Type 4; Humans; Image Processing, Computer-Assisted; Imatinib Mesylate; Male; Middle Aged; Mutation; Neoadjuvant Therapy; Piperazines; Positron-Emission Tomography; Proto-Oncogene Proteins c-kit; Pyrimidines; Time Factors; Treatment Outcome; Young Adult | 2012 |
18FDG-Positron emission tomography for the early prediction of response in advanced soft tissue sarcoma treated with imatinib mesylate (Glivec).
Topics: Adult; Aged; Antineoplastic Agents; Benzamides; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Imatinib Mesylate; Male; Middle Aged; Piperazines; Prospective Studies; Pyrimidines; Radiopharmaceuticals; Sarcoma; Survival Analysis; Tomography, Emission-Computed; Treatment Failure | 2003 |
The role of 18F-FDG PET in staging and early prediction of response to therapy of recurrent gastrointestinal stromal tumors.
Topics: Adult; Aged; Aged, 80 and over; Benzamides; False Positive Reactions; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Imatinib Mesylate; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Piperazines; Prognosis; Pyrimidines; Radiography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic; Stromal Cells; Tomography, Emission-Computed; Treatment Outcome | 2004 |
[F-18] fluorodeoxyglucose positron emission tomography as a tool for early recognition of incomplete tumor destruction after radiofrequency ablation for liver metastases.
Topics: Breast Neoplasms; Catheter Ablation; Colonic Neoplasms; Disease-Free Survival; Fluorodeoxyglucose F18; Follow-Up Studies; Gastrointestinal Neoplasms; Hepatectomy; Humans; Liver; Liver Neoplasms; Neoplasm Recurrence, Local; Postoperative Period; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
Imatinib mesylate for the treatment of gastrointestinal stromal tumours: best monitored with FDG PET.
Topics: Adult; Aged; Antineoplastic Agents; Benzamides; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Imatinib Mesylate; Middle Aged; Piperazines; Positron-Emission Tomography; Prognosis; Pyrimidines; Radiopharmaceuticals; Reproducibility of Results; Sarcoma; Sensitivity and Specificity; Treatment Outcome | 2004 |
Coincidence imaging using 2 dual-head gamma-camera systems, with and without attenuation correction.
Topics: Adult; Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Gamma Cameras; Gastrointestinal Neoplasms; Humans; Image Enhancement; Lung Neoplasms; Lymphoma, Non-Hodgkin; Male; Melanoma; Middle Aged; Ovarian Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed | 2004 |
The value of PET, CT and in-line PET/CT in patients with gastrointestinal stromal tumours: long-term outcome of treatment with imatinib mesylate.
Topics: Adult; Aged; Antineoplastic Agents; Benzamides; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gastrointestinal Neoplasms; Humans; Imatinib Mesylate; Longitudinal Studies; Male; Middle Aged; Piperazines; Positron-Emission Tomography; Prognosis; Pyrimidines; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Survival Analysis; Switzerland; Tomography, X-Ray Computed; Treatment Outcome | 2005 |
Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I study.
Topics: Adult; Aged; Antineoplastic Agents; Benzamides; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Imatinib Mesylate; Male; Middle Aged; Piperazines; Pyrimidines; Radionuclide Imaging; Treatment Outcome | 2001 |
67 other study(ies) available for fluorodeoxyglucose f18 and Cancer of Gastrointestinal Tract
| Article | Year |
|---|---|
Utility of PET Scans in the Diagnosis and Management of Gastrointestinal Tumors.
Topics: Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2022 |
Multicystic Biliary Hamartoma With Xanthogranulomatous Inflammation on 18F-FDG PET/CT.
Topics: Aged; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cysts; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Hamartoma; Humans; Inflammation; Liver Neoplasms; Male; Positron Emission Tomography Computed Tomography | 2022 |
Gastroenteropancreatic neuroendocrine neoplasm imaging: standard reporting templates.
Topics: Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Neuroendocrine Tumors; Pancreatic Neoplasms; Receptors, Somatostatin | 2022 |
Impact of 68 Ga-FAPI-04 PET/CT on Staging and Therapeutic Management in Patients With Digestive System Tumors.
Topics: Adenocarcinoma; Carcinoma, Hepatocellular; Carcinoma, Pancreatic Ductal; Colonic Neoplasms; Digestive System Neoplasms; Fluorodeoxyglucose F18; Gallium Radioisotopes; Gastrointestinal Neoplasms; Humans; Liver Neoplasms; Neuroendocrine Tumors; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography | 2023 |
Dual [
Topics: Fluorodeoxyglucose F18; Gallium Radioisotopes; Gastrointestinal Neoplasms; Humans; Neuroendocrine Tumors; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2023 |
Detection of Bone Metastases by
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Gallium Radioisotopes; Gastrointestinal Neoplasms; Humans; Ki-67 Antigen; Neuroendocrine Tumors; Osteolysis; Positron Emission Tomography Computed Tomography; Receptors, Somatostatin; Retrospective Studies | 2022 |
Role of 68 Ga-FAPI PET/CT in Assessing Hepatobiliary Malignancies : A Prospective Pilot Study.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Cholangiocarcinoma; Fibroblasts; Fluorodeoxyglucose F18; Gallium Radioisotopes; Gastrointestinal Neoplasms; Humans; Liver Neoplasms; Pilot Projects; Positron Emission Tomography Computed Tomography; Prospective Studies | 2023 |
Early Evaluation of Response Using
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Male; Middle Aged; Neoadjuvant Therapy; Positron-Emission Tomography; Retrospective Studies; Time Factors; Treatment Outcome; Young Adult | 2018 |
Prognostic Value of Computed Tomography: Measured Parameters of Body Composition in Primary Operable Gastrointestinal Cancers: Methodologic Issues.
Topics: Body Composition; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Prognosis; Tomography, X-Ray Computed | 2017 |
Potential clinical value of quantitative fluorine-18-fluorodeoxyglucose-PET/computed tomography using a graph-based method analysis in evaluation of incidental lesions of gastrointestinal tract: correlation with endoscopic and histopathological findings.
Topics: Adult; Endoscopy, Gastrointestinal; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Glycolysis; Humans; Image Processing, Computer-Assisted; Incidental Findings; Male; Positron Emission Tomography Computed Tomography; Retrospective Studies; Tumor Burden | 2019 |
The Maximum standardized uptake value is more reliable than size measurement in early follow-up to evaluate potential pulmonary malignancies following radiofrequency ablation.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Catheter Ablation; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gastrointestinal Neoplasms; Humans; Kidney Neoplasms; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Tomography, X-Ray Computed | 2013 |
Diffusion-weighted magnetic resonance imaging in metastatic gastrointestinal stromal tumor (GIST): a pilot study on the assessment of treatment response in comparison with 18F-FDG PET/CT.
Topics: Contrast Media; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Image Enhancement; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Liver Neoplasms; Male; Meglumine; Middle Aged; Multimodal Imaging; Observer Variation; Organometallic Compounds; Pilot Projects; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Treatment Outcome | 2013 |
Utilisation of combined 18F-FDG PET/CT scan for differential diagnosis between benign and malignant adrenal enlargement.
Topics: Adrenal Gland Neoplasms; Adrenal Glands; Adult; Aged; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2013 |
The usefulness of preoperative 18FDG positron-emission tomography and computed tomography for predicting the malignant potential of gastrointestinal stromal tumors.
Topics: Adult; Aged; Aged, 80 and over; Cell Transformation, Neoplastic; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Ki-67 Antigen; Male; Middle Aged; Mitotic Index; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Tomography, X-Ray Computed; Tumor Burden | 2014 |
¹⁸F-FDG PET/CT imaging for a gastrointestinal mantle cell lymphoma with multiple lymphomatous polyposis.
Topics: Adenomatous Polyps; Cell Proliferation; Endoscopy, Gastrointestinal; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Intestinal Polyposis; Ki-67 Antigen; Lymphoma, Mantle-Cell; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Stomach Neoplasms; Tomography, X-Ray Computed | 2014 |
[Importance of PET for surgery of gastrointestinal stromal tumors].
Topics: Combined Modality Therapy; Energy Metabolism; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Molecular Imaging; Neoadjuvant Therapy; Positron-Emission Tomography; Prognosis; Sensitivity and Specificity; Tumor Burden | 2014 |
Dual tracer imaging approach in assessing tumor biology and heterogeneity in neuroendocrine tumors: its correlation with tumor proliferation index and possible multifaceted implications for personalized clinical management decisions, with focus on PRRT.
Topics: Adult; Cell Proliferation; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Neuroendocrine Tumors; Octreotide; Organotechnetium Compounds; Positron-Emission Tomography; Precision Medicine; Radiopharmaceuticals; Somatostatin; Tomography, X-Ray Computed | 2014 |
Prognostic stratification of metastatic gastroenteropancreatic neuroendocrine neoplasms by 18F-FDG PET: feasibility of a metabolic grading system.
Topics: Adult; Aged; Aged, 80 and over; Feasibility Studies; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Ki-67 Antigen; Male; Middle Aged; Neoplasm Grading; Neoplasm Metastasis; Neuroendocrine Tumors; Pancreatic Neoplasms; Positron-Emission Tomography; Prognosis; Retrospective Studies; Survival Analysis | 2014 |
Unusual loss of FDG uptake in recurrent GIST.
Topics: Adult; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Male; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Tissue Distribution; Tomography, X-Ray Computed | 2014 |
Detection of liver metastases in patients with adenocarcinomas of the gastrointestinal tract: comparison of (18)F-FDG PET/CT and MR imaging.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2015 |
Assessment of early response to imatinib 800 mg after 400 mg progression by ¹⁸F-fluorodeoxyglucose PET in patients with metastatic gastrointestinal stromal tumors.
Topics: Adult; Aged; Antineoplastic Agents; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Image Interpretation, Computer-Assisted; Imatinib Mesylate; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Prospective Studies; Protein Kinase Inhibitors; Survival Analysis; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
Diffusion-weighted whole-body imaging with background body signal suppression/T2 image fusion and positron emission tomography/computed tomography of upper gastrointestinal cancers.
Topics: Aged; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Male; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Upper Gastrointestinal Tract; Whole Body Imaging | 2015 |
Primary Prostatic Extragastrointestinal Stromal Tumor on 18F-FDG PET/CT.
Topics: Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Male; Multimodal Imaging; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, X-Ray Computed | 2016 |
Clinicopathologic Features and Molecular Characteristics of Glucose Metabolism Contributing to ¹⁸F-fluorodeoxyglucose Uptake in Gastrointestinal Stromal Tumors.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Carrier Proteins; DNA Mutational Analysis; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Gene Expression; Glucose; Glucose Transporter Type 1; Hexokinase; Humans; Immunohistochemistry; Isoenzymes; L-Lactate Dehydrogenase; Lactate Dehydrogenase 5; Male; Membrane Proteins; Middle Aged; Mutation; Neoplasm Grading; Positron-Emission Tomography; Thyroid Hormone-Binding Proteins; Thyroid Hormones; Tomography, X-Ray Computed; Tumor Burden; Young Adult | 2015 |
The predictive value of preoperative
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Gastrointestinal Tract; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Postoperative Period; Predictive Value of Tests; Preoperative Care; Radiopharmaceuticals; Retrospective Studies | 2016 |
Gastrointestinal stromal tumour in neurofibromatosis 1: 18F FDG PET/CT imaging.
Topics: Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Jejunal Neoplasms; Middle Aged; Neurofibromatosis 1; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2016 |
Impact of fluorodihydroxyphenylalanine-18F positron emission tomography on management of adult patients with documented or occult digestive endocrine tumors.
Topics: Adult; Biopsy; Carcinoid Tumor; Dihydroxyphenylalanine; Endocrine Gland Neoplasms; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Ileal Neoplasms; Neoplasm Metastasis; Positron-Emission Tomography | 2009 |
Gastrointestinal 18F-FDG accumulation on PET without a corresponding CT abnormality is not an early indicator of cancer development.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Diagnostic Errors; False Positive Reactions; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed; Whole Body Imaging; Young Adult | 2009 |
Feasibility of integrated CT-liver perfusion in routine FDG-PET/CT.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Contrast Media; Feasibility Studies; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Iohexol; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Perfusion Imaging; Positron-Emission Tomography; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Statistics, Nonparametric; Tomography, X-Ray Computed | 2010 |
[The role of positron emission tomography in the detection of incidental gastrointestinal tract lesions in patients examined for lung cancer].
Topics: Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Incidental Findings; Lung Neoplasms; Male; Middle Aged; Neoplasms, Multiple Primary; Positron-Emission Tomography; Retrospective Studies | 2010 |
Multiple primary malignant tumors of upper gastrointestinal tract: a novel role of 18F-FDG PET/CT.
Topics: Aged; Biopsy; China; Endoscopy, Gastrointestinal; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Lymph Nodes; Male; Middle Aged; Neoplasm Staging; Neoplasms, Multiple Primary; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Whole Body Imaging | 2010 |
Postoperative FDG-PET/CT staging in GIST: is there a benefit following R0 resection?
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Postoperative Care; Radiopharmaceuticals; Subtraction Technique; Tomography, X-Ray Computed; Treatment Outcome | 2011 |
Clinically unrecognized pulmonary aspiration during gastrointestinal endoscopy with sedation: a potential pitfall interfering the performance of 18F-FDG PET for cancer screening.
Topics: Adult; Aged; Aged, 80 and over; Anesthesia; Artifacts; Endoscopy, Gastrointestinal; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Incidental Findings; Lung Diseases; Male; Mass Screening; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2011 |
Correlation of measurements from diffusion weighted MR imaging and FDG PET/CT in GIST patients: ADC versus SUV.
Topics: Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic; Tomography, X-Ray Computed | 2012 |
The clinical value of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in postoperative patients with gastrointestinal mucinous adenocarcinoma.
Topics: Adenocarcinoma, Mucinous; Adult; Aged; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gastrointestinal Neoplasms; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Peritoneum; Positron-Emission Tomography; Postoperative Period; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2011 |
Characterization of adrenal metastatic cancer using FDG PET/CT.
Topics: Adrenal Gland Neoplasms; Adrenal Glands; Aged; Carcinoma; China; Cohort Studies; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Hyperplasia; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Risk; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Intratumoral heterogeneity of F-18 FDG uptake differentiates between gastrointestinal stromal tumors and abdominal malignant lymphomas on PET/CT.
Topics: Abdominal Neoplasms; Biological Transport; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Lymphoma; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed | 2012 |
Incongruity of imaging using fluorescent 2-DG conjugates compared to 18F-FDG in preclinical cancer models.
Topics: Animals; Deoxyglucose; Fluorescence; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Imaging, Three-Dimensional; Luminescent Measurements; Mice; Mice, Nude; Microscopy, Confocal; Pyrimidines; Radionuclide Imaging; Spectroscopy, Near-Infrared; Xenograft Model Antitumor Assays | 2012 |
Comparison of FDG-PET/CT and MR with diffusion-weighted imaging for assessing peritoneal carcinomatosis from gastrointestinal malignancy.
Topics: Adult; Aged; Aged, 80 and over; Diffusion Magnetic Resonance Imaging; Early Diagnosis; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Peritoneal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2012 |
Correlation of dynamic PET and gene array data in patients with gastrointestinal stromal tumors.
Topics: Adult; Biomarkers, Tumor; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Gene Expression Profiling; Humans; Male; Middle Aged; Neoplasm Proteins; Positron-Emission Tomography; Protein Array Analysis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic | 2012 |
Patterns of extension of gastrointestinal stromal tumors (GIST) treated with imatinib (Gleevec®) by 18F-FDG PET/CT.
Topics: Aged; Antineoplastic Agents; Benzamides; Drug Monitoring; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Piperazines; Positron-Emission Tomography; Pyrimidines; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
[Value of dual-time-point (18)F-fluorodeoxyglucose integrated positron emission and computed tomography in differentiation of malignant from benign gastrointestinal diseases].
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Colitis; Colorectal Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gastritis; Gastrointestinal Diseases; Gastrointestinal Neoplasms; Humans; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Proctitis; Proctocolitis; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Stomach Neoplasms; Tomography, X-Ray Computed | 2012 |
PET/CT in oncology.
Topics: Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Lung Neoplasms; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2012 |
Efficacy of PET-CT for predicting the malignant potential of gastrointestinal stromal tumors.
Topics: Adult; Aged; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Risk; Tomography, X-Ray Computed | 2013 |
Diagnostic role of 18F-fluorodeoxyglucose positron emission tomography for follicular lymphoma with gastrointestinal involvement.
Topics: Adult; Aged; Chi-Square Distribution; Endoscopy, Gastrointestinal; Feasibility Studies; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Japan; Lymphoma, Follicular; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies | 2012 |
Imaging features of primary anorectal gastrointestinal stromal tumors with clinical and pathologic correlation.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2013 |
An FDG positron emission tomographic study in a case of gastrointestinal stromal tumor.
Topics: Appendiceal Neoplasms; Benzamides; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gastrointestinal Neoplasms; Humans; Imatinib Mesylate; Jejunal Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Piperazines; Pyrimidines; Radionuclide Imaging; Radiopharmaceuticals; Treatment Outcome | 2003 |
F-18 FDG PET imaging in gastrointestinal stromal tumor.
Topics: Antineoplastic Agents; Benzamides; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Imatinib Mesylate; Liver Neoplasms; Piperazines; Pyrimidines; Radiopharmaceuticals; Stromal Cells; Tomography, Emission-Computed; Whole-Body Counting | 2003 |
[18F]5-fluoro-2-deoxyuridine-PET for imaging of malignant tumors and for measuring tissue proliferation.
Topics: Adult; Aged; Bone and Bones; Cell Division; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Ki-67 Antigen; Kidney; Liver; Lung Neoplasms; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Neoplasms; Prospective Studies; Radiopharmaceuticals; Sarcoma; Tissue Distribution; Tomography, Emission-Computed; Urinary Bladder | 2003 |
[FDG-PET and CT in gastrointestinal stromal tumor treated with imatinib].
Topics: Antineoplastic Agents; Benzamides; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Imatinib Mesylate; Middle Aged; Piperazines; Pyrimidines; Radiopharmaceuticals; Stromal Cells; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
18F-FDG-PET in metastatic gastrointestinal stromal tumour.
Topics: Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Metastasis; Stromal Cells; Tomography, Emission-Computed; Treatment Outcome | 2004 |
[A case of enhanced FDG uptake in esophageal GIST (gastrointestinal stromal tumor)].
Topics: Aged; Esophageal Neoplasms; Esophagus; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Image Enhancement; Stromal Cells; Tomography, Emission-Computed | 2004 |
18F-FDG PET for evaluation of the treatment response in patients with gastrointestinal tract lymphomas.
Topics: Adult; Aged; Antineoplastic Agents; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Lymphoma; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Treatment Outcome | 2004 |
Significance of incidental 18F-FDG accumulations in the gastrointestinal tract in PET/CT: correlation with endoscopic and histopathologic results.
Topics: Aged; Aged, 80 and over; Endoscopy, Digestive System; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Gastrointestinal Tract; Humans; Incidental Findings; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic; Subtraction Technique; Tomography, X-Ray Computed | 2004 |
PET/CT detection of unexpected gastrointestinal foci of 18F-FDG uptake: incidence, localization patterns, and clinical significance.
Topics: Adult; Aged; Aged, 80 and over; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Incidence; Incidental Findings; Israel; Middle Aged; Positron-Emission Tomography; Precancerous Conditions; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Subtraction Technique; Tissue Distribution; Tomography, X-Ray Computed | 2005 |
Multimodal treatment of gastrointestinal tract tumors: consequences for surgery.
Topics: Combined Modality Therapy; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Neoplasm Staging; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Risk Assessment; Survival Analysis | 2005 |
Detection of liver metastases from gastrointestinal cancer: comparision of high resolution MnDPDP enhanced MRI and FDG-PET.
Topics: Adenocarcinoma; Adult; Aged; Contrast Media; Edetic Acid; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Pyridoxal Phosphate; Radiopharmaceuticals; Sensitivity and Specificity | 2005 |
Lymphomatous involvement of gastrointestinal tract: evaluation by positron emission tomography with (18)F-fluorodeoxyglucose.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed | 2005 |
[Roles of F-18 FDG PET or PET/CT for the evaluation of gastrointestinal malignancies].
Topics: Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2006 |
[Evaluation of FDG-PET imaging for the detection of gastrointestinal tract cancer in patients with suspected lung cancer].
Topics: Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasms, Multiple Primary; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2006 |
Colorectal tubulovillous adenomas identified on fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography scans.
Topics: Adenoma, Villous; Adenomatous Polyps; Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Head and Neck Neoplasms; Humans; Incidental Findings; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed | 2008 |
Metastasis of the gastrointestinal tract: FDG-PET imaging.
Topics: Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2007 |
Role of positron emission tomography scanning in evaluating gastrointestinal neoplasms.
Topics: Colorectal Neoplasms; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Pancreatic Neoplasms; Sensitivity and Specificity; Tomography, Emission-Computed | 1996 |
Can dual-headed 18F-FDG SPET imaging reliably supersede PET in clinical oncology? A comparative study in lung and gastrointestinal tract cancer.
Topics: Colorectal Neoplasms; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gamma Cameras; Gastrointestinal Neoplasms; Humans; Lung Neoplasms; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Pancreatic Neoplasms; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1998 |
Whole-body 18F dopa PET for detection of gastrointestinal carcinoid tumors.
Topics: Adult; Aged; Carcinoid Tumor; Dihydroxyphenylalanine; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Receptors, Somatostatin; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2001 |
Positron emission tomography: the gastroenterologists's perspective.
Topics: Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Radiopharmaceuticals; Tomography, Emission-Computed | 2002 |
[Evaluation of gastroenterological disease by using 18F-FDG PET--differential diagnosis of malignancy from benignity].
Topics: Deoxyglucose; Diagnosis, Differential; Fluorodeoxyglucose F18; Gastrointestinal Diseases; Gastrointestinal Neoplasms; Humans; Japan; Retrospective Studies; Tomography, Emission-Computed | 1992 |